We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-1.91%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$151M
AUM Growth
+$10.1M
Cap. Flow
+$16.3M
Cap. Flow %
10.8%
Top 10 Hldgs %
48.77%
Holding
155
New
39
Increased
47
Reduced
18
Closed
28

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$8.86M
2
KSU
Kansas City Southern
KSU
+$3.59M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$3.54M
4
PPD
PPD, Inc. Common Stock
PPD
+$3.47M
5
FIVN icon
FIVE9
FIVN
+$3.18M

Top Sells

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$9.44M
2
MXIM
Maxim Integrated Products
MXIM
+$4.49M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.96M
4
WORK
Slack Technologies, Inc.
WORK
+$3.57M
5
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 44.08%
2 Technology 31.3%
3 Consumer Discretionary 7.05%
4 Communication Services 3.66%
5 Industrials 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRA icon
101
Vera Bradley
VRA
$95.3M
$99K 0.07%
10,541
-5,626
-35% -$61.6K
ORN icon
102
Orion Group Holdings
ORN
$397M
$97K 0.06%
17,715
– –
ONCT
103
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$97K 0.06%
+1,156
New +$95.6K
LITS
104
Lite Strategy Inc
LITS
$30.9M
$95K 0.06%
1,716
– –
SND icon
105
Smart Sand
SND
$198M
$95K 0.06%
+38,651
New +$99K
CMRX
106
DELISTED
Chimerix, Inc.
CMRX
$94K 0.06%
+15,212
New +$105K
CECO icon
107
Ceco Environmental
CECO
$4.29B
$93K 0.06%
13,180
– –
PRTK
108
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$93K 0.06%
+19,182
New +$106K
RNAC icon
109
Cartesian Therapeutics
RNAC
$257M
$92K 0.06%
+742
New +$89.6K
SMED
110
DELISTED
Sharps Compliance Corp
SMED
$92K 0.06%
+11,206
New +$104K
NPTN
111
DELISTED
NEOPHOTONICS CORP
NPTN
$92K 0.06%
10,633
– –
LINC icon
112
Lincoln Educational Services
LINC
$963M
$84K 0.06%
12,541
– –
LYTS icon
113
LSI Industries
LYTS
$906M
$84K 0.06%
10,800
– –
PBYI icon
114
Puma Biotechnology
PBYI
$459M
$84K 0.06%
+11,972
New +$89.6K
ARAY icon
115
Accuray
ARAY
$35.1M
$82K 0.05%
20,938
– –
RLGT icon
116
Radiant Logistics
RLGT
$389M
$82K 0.05%
12,900
– –
III icon
117
Information Services Group
III
$250M
$79K 0.05%
11,006
– –
RIGL icon
118
Rigel Pharmaceuticals
RIGL
$778M
$79K 0.05%
2,174
+851
+64% +$33.5K
VMD icon
119
Viemed Healthcare
VMD
$353M
$78K 0.05%
+14,110
New +$91.8K
PCTI
120
DELISTED
PCTEL, Inc. Common Stock
PCTI
$75K 0.05%
12,188
– –
LOMA
121
Loma Negra
LOMA
$1.16B
$73K 0.05%
10,276
-1,302
-11% -$9.71K
ARQ icon
122
Arq
ARQ
$95.7M
$73K 0.05%
+11,495
New +$79.1K
HOOK
123
DELISTED
HOOKIPA Pharma
HOOK
$71K 0.05%
+1,205
New +$87.4K
DAKT icon
124
Daktronics
DAKT
$1.02B
$69K 0.05%
+12,621
New +$74.9K
RBBN icon
125
Ribbon Communications
RBBN
$358M
$60K 0.04%
10,011
– –
3 4
5
6 7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2021 Portfolio in Review

As of Q3 2021, HighVista Strategies held 155 positions worth $151M, up 7.2% from $141M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HighVista Strategies deployed $16.3M of net new capital in Q3 2021, opening 39 new positions and adding to 47 existing holdings. Its largest new stake was Coupang: 256,264 shares worth $7.14M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $1.39M trimmed.

  • HighVista Strategies's largest Q3 2021 buy was Coupang: 256,264 shares worth $7.14M.
  • HighVista Strategies added most to ESSA Pharma in Q3 2021, an estimated $1.9M increase.
  • HighVista Strategies's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.39M.
  • HighVista Strategies fully exited Willis Towers Watson in Q3 2021, selling an estimated $9.44M.
  • HighVista Strategies's ten largest holdings make up 49% of its $151M portfolio in Q3 2021.
  • HighVista Strategies opened 39 new positions and closed 28 in Q3 2021.
  • HighVista Strategies's portfolio value rose 7.2% quarter-over-quarter to $151M.

Based on HighVista Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.